LAMEA Inhalation Capsules Market Size, Share & Trends Analysis Report By Type (Gelatin Capsules, and Hypromellose Capsules), By Application (Asthma Treatment, COPD Management, and Others). By Country and Growth Forecast, 2024 - 2031

The Latin America, Middle East and Africa Inhalation Capsules Market would witness market growth of 7.8% CAGR during the forecast period (2024-2031).

The Brazil market dominated the LAMEA Inhalation Capsules Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $36.4 Million by 2031. The Argentina market is showcasing a CAGR of 8.4% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 7.4% during (2024 - 2031).

The focus on respiratory health and disease management is a significant catalyst for the growth of the inhalation capsules market by driving awareness, improving treatment outcomes, and fostering innovation in inhalation therapy. As respiratory diseases pose significant health challenges, the demand for effective and patient-friendly treatment options delivered via inhalation capsules will remain robust.

Additionally, one of the primary drivers behind the growth of the inhalation capsules market is the continuous innovation in inhalation device technologies. Manufacturers are developing advanced DPIs with improved drug delivery efficiency, dose accuracy, and patient convenience. These innovations include integrating smart features such as dose counters, feedback mechanisms, and connectivity options, allowing for better medication adherence and monitoring. Developing novel formulations and combination therapies delivered via inhalation capsules further expands the therapeutic options available to patients, driving market growth.

In the LAMEA region, the demand for inhalation capsules is rising, driven by various factors unique to each country. Brazil, for instance, boasts the largest healthcare sector in Latin America, allocating a significant portion of its GDP, around 9.47% or US$161 billion, to healthcare. Hence, the evolving healthcare landscape drives the rising demand for inhalation capsules in the LAMEA region.

Free Valuable Insights: The Worldwide Inhalation Capsules Market is Projected to reach USD 1.4 Billion by 2031, at a CAGR of 5.9%

Based on Type, the market is segmented into Gelatin Capsules, and Hypromellose Capsules. Based on Application, the market is segmented into Asthma Treatment, COPD Management, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

• Cipla Limited
• Novartis AG
• AstraZeneca PLC
• Boehringer Ingelheim International GmbH
• Lonza Group Ltd. (Capsugel)
• Chiesi Farmaceutici S.p.A
• Vectura Group Plc (Philip Morris International, Inc.)
• Elpen S.A.
• Healthcaps India Ltd.
• Qualicaps Co., LTD. (Roquette Freres SA)

LAMEA Inhalation Capsules Market Report Segmentation

By Type

• Gelatin Capsules
• Hypromellose Capsules

By Application

• Asthma Treatment
• COPD Management
• Others

By Country

• Brazil
• Argentina
• UAE
• Saudi Arabia
• South Africa
• Nigeria
• Rest of LAMEA

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Inhalation Capsules Market, by Type
1.4.2 LAMEA Inhalation Capsules Market, by Application
1.4.3 LAMEA Inhalation Capsules Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance
2.1 Key Highlights

Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
3.3 Porter’s Five Forces Analysis

Chapter 4. Recent Strategies Deployed in Inhalation Capsules Market

Chapter 5. LAMEA Inhalation Capsules Market by Type
5.1 LAMEA Gelatin Capsules Market by Country
5.2 LAMEA Hypromellose Capsules Market by Country

Chapter 6. LAMEA Inhalation Capsules Market by Application
6.1 LAMEA Asthma Treatment Market by Country
6.2 LAMEA COPD Management Market by Country
6.3 LAMEA Others Market by Country

Chapter 7. LAMEA Inhalation Capsules Market by Country
7.1 Brazil Inhalation Capsules Market
7.1.1 Brazil Inhalation Capsules Market by Type
7.1.2 Brazil Inhalation Capsules Market by Application
7.2 Argentina Inhalation Capsules Market
7.2.1 Argentina Inhalation Capsules Market by Type
7.2.2 Argentina Inhalation Capsules Market by Application
7.3 UAE Inhalation Capsules Market
7.3.1 UAE Inhalation Capsules Market by Type
7.3.2 UAE Inhalation Capsules Market by Application
7.4 Saudi Arabia Inhalation Capsules Market
7.4.1 Saudi Arabia Inhalation Capsules Market by Type
7.4.2 Saudi Arabia Inhalation Capsules Market by Application
7.5 South Africa Inhalation Capsules Market
7.5.1 South Africa Inhalation Capsules Market by Type
7.5.2 South Africa Inhalation Capsules Market by Application
7.6 Nigeria Inhalation Capsules Market
7.6.1 Nigeria Inhalation Capsules Market by Type
7.6.2 Nigeria Inhalation Capsules Market by Application
7.7 Rest of LAMEA Inhalation Capsules Market
7.7.1 Rest of LAMEA Inhalation Capsules Market by Type
7.7.2 Rest of LAMEA Inhalation Capsules Market by Application

Chapter 8. Company Profiles
8.1 Cipla Limited
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expense
8.1.5 SWOT Analysis
8.2 Novartis AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Trials and Approvals:
8.2.6 SWOT Analysis
8.3 AstraZeneca PLC
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Trials and Approvals:
8.3.6 SWOT Analysis
8.4 Boehringer Ingelheim International GmbH
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Regional & Segmental Analysis
8.4.4 Research & Development Expenses
8.4.5 SWOT Analysis
8.5 Lonza Group Ltd. (Capsugel)
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental and Regional Analysis
8.5.4 Research & Development Expenses
8.5.5 SWOT Analysis
8.6 Chiesi Farmaceutici S.p.A
8.6.1 Company Overview
8.6.2 Recent strategies and developments:
8.6.2.1 Partnerships, Collaborations, and Agreements:
8.6.2.2 Product Launches and Product Expansions:
8.6.3 SWOT Analysis
8.7 Vectura Group plc (Philip Morris International, Inc.)
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Regional Analysis
8.7.4 Research & Development Expenses
8.7.5 Recent strategies and developments:
8.7.5.1 Partnerships, Collaborations, and Agreements:
8.7.5.2 Geographical Expansions:
8.7.6 SWOT Analysis
8.8 Elpen S.A.
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Healthcaps India Ltd.
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Qualicaps Co., LTD. (Roquette Freres SA)
8.10.1 Company Overview
8.10.2 SWOT Analysis

TABLE 1 LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 2 LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 3 LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 4 LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 5 LAMEA Gelatin Capsules Market by Country, 2020 - 2023, USD Million
TABLE 6 LAMEA Gelatin Capsules Market by Country, 2024 - 2031, USD Million
TABLE 7 LAMEA Hypromellose Capsules Market by Country, 2020 - 2023, USD Million
TABLE 8 LAMEA Hypromellose Capsules Market by Country, 2024 - 2031, USD Million
TABLE 9 LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 10 LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 11 LAMEA Asthma Treatment Market by Country, 2020 - 2023, USD Million
TABLE 12 LAMEA Asthma Treatment Market by Country, 2024 - 2031, USD Million
TABLE 13 LAMEA COPD Management Market by Country, 2020 - 2023, USD Million
TABLE 14 LAMEA COPD Management Market by Country, 2024 - 2031, USD Million
TABLE 15 LAMEA Others Market by Country, 2020 - 2023, USD Million
TABLE 16 LAMEA Others Market by Country, 2024 - 2031, USD Million
TABLE 17 LAMEA Inhalation Capsules Market by Country, 2020 - 2023, USD Million
TABLE 18 LAMEA Inhalation Capsules Market by Country, 2024 - 2031, USD Million
TABLE 19 Brazil Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 20 Brazil Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 21 Brazil Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 22 Brazil Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 23 Brazil Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 24 Brazil Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 25 Argentina Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 26 Argentina Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 27 Argentina Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 28 Argentina Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 29 Argentina Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 30 Argentina Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 31 UAE Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 32 UAE Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 33 UAE Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 34 UAE Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 35 UAE Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 36 UAE Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 37 Saudi Arabia Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 38 Saudi Arabia Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 39 Saudi Arabia Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 40 Saudi Arabia Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 41 Saudi Arabia Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 42 Saudi Arabia Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 43 South Africa Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 44 South Africa Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 45 South Africa Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 46 South Africa Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 47 South Africa Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 48 South Africa Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 49 Nigeria Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 50 Nigeria Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 51 Nigeria Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 52 Nigeria Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 53 Nigeria Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 54 Nigeria Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 55 Rest of LAMEA Inhalation Capsules Market, 2020 - 2023, USD Million
TABLE 56 Rest of LAMEA Inhalation Capsules Market, 2024 - 2031, USD Million
TABLE 57 Rest of LAMEA Inhalation Capsules Market by Type, 2020 - 2023, USD Million
TABLE 58 Rest of LAMEA Inhalation Capsules Market by Type, 2024 - 2031, USD Million
TABLE 59 Rest of LAMEA Inhalation Capsules Market by Application, 2020 - 2023, USD Million
TABLE 60 Rest of LAMEA Inhalation Capsules Market by Application, 2024 - 2031, USD Million
TABLE 61 Key Information – Cipla Limited
TABLE 62 Key Information – Novartis AG
TABLE 63 Key Information – AstraZeneca PLC
TABLE 64 Key Information – Boehringer Ingelheim International GmbH
TABLE 65 Key Information –Lonza Group Ltd.
TABLE 66 Key Information – Chiesi Farmaceutici S.p.A
TABLE 67 Key Information – Vectura Group plc
TABLE 68 Key Information – Elpen S.A.
TABLE 69 Key Information – Healthcaps India Ltd.
TABLE 70 Key Information – Qualicaps Co., LTD.

List of Figures
FIG 1 Methodology for the research
FIG 2 LAMEA Inhalation Capsules Market, 2020 - 2031, USD Million
FIG 3 Key Factors Impacting Inhalation Capsules Market
FIG 4 Porter’s Five Forces Analysis – Inhalation capsules market
FIG 5 LAMEA Inhalation Capsules Market share by Type, 2023
FIG 6 LAMEA Inhalation Capsules Market share by Type, 2031
FIG 7 LAMEA Inhalation Capsules Market by Type, 2020 - 2031, USD Million
FIG 8 LAMEA Inhalation Capsules Market share by Application, 2023
FIG 9 LAMEA Inhalation Capsules Market share by Application, 2031
FIG 10 LAMEA Inhalation Capsules Market by Application, 2020 - 2031, USD Million
FIG 11 LAMEA Inhalation Capsules Market share by Country, 2023
FIG 12 LAMEA Inhalation Capsules Market share by Country, 2031
FIG 13 LAMEA Inhalation Capsules Market by Country, 2020 - 2031, USD Million
FIG 14 SWOT Analysis: Cipla Limited
FIG 15 SWOT Analysis: Novartis AG
FIG 16 Recent strategies and developments: AstraZeneca PLC
FIG 17 SWOT Analysis: AstraZeneca PLC
FIG 18 SWOT Analysis: Boehringer Ingelheim International GmbH
FIG 19 Swot Analysis: Lonza Group Ltd.
FIG 20 Recent strategies and developments: Chiesi Farmaceutici S.p.A.
FIG 21 SWOT Analysis: Chiesi Farmaceutici S.p.A
FIG 22 Recent strategies and developments: Vectura Group plc
FIG 23 Swot Analysis: Vectura Group plc
FIG 24 Swot Analysis: elpen s.a.
FIG 25 Swot Analysis: Healthcaps India Ltd.
FIG 26 Swot Analysis: Qualicaps Co., LTD.